
The newest aspects for the use of cytostatic agents in the treatment of bladder, prostatic and testicular carcinomas are presented. Especially the two new drugs diaminodichlor cisplatinum and adriamycin are discussed as to their potential use in these diseases.
Male, Ovarian Neoplasms, Urologic Neoplasms, Testicular Neoplasms, Urinary Bladder Neoplasms, Doxorubicin, Humans, Drug Synergism, Female, Cisplatin, Kidney, Kidney Neoplasms
Male, Ovarian Neoplasms, Urologic Neoplasms, Testicular Neoplasms, Urinary Bladder Neoplasms, Doxorubicin, Humans, Drug Synergism, Female, Cisplatin, Kidney, Kidney Neoplasms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
